Brought to you by 
Valeant scoops up Solta Medical for $237mm in cash
27 Aug 2020
Executive Summary
Further enhancing its dermatology portfolio, Valeant Pharmaceuticals International Inc. agreed to pay $237mm ($2.92 per share in cash; a 41% premium) to acquire public aesthetics device maker Solta Medical Inc.
Deal Industry
- Medical Devices
-
Medical Devices
- Laser
- Radiofrequency Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Valeant scoops up Solta Medical for $237mm in cash
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice